DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 91 filers reported holding DYNE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $703 | +0.7% | 61,003 | +1.2% | 0.01% | -21.4% |
| Q4 2022 | $698 | -99.8% | 60,257 | +130.0% | 0.01% | +100.0% |
| Q3 2022 | $333,000 | -30.8% | 26,200 | -62.6% | 0.01% | -46.2% |
| Q2 2022 | $481,000 | -9.4% | 70,063 | +27.1% | 0.01% | +8.3% |
| Q1 2022 | $531,000 | +14.2% | 55,131 | +40.9% | 0.01% | +50.0% |
| Q4 2021 | $465,000 | -4.9% | 39,115 | +68.4% | 0.01% | -11.1% |
| Q2 2021 | $489,000 | -57.3% | 23,230 | -68.5% | 0.01% | -60.9% |
| Q1 2021 | $1,145,000 | +406.6% | 73,758 | +585.1% | 0.02% | +283.3% |
| Q4 2020 | $226,000 | -16.9% | 10,766 | -20.1% | 0.01% | -50.0% |
| Q3 2020 | $272,000 | – | 13,474 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $25,730,194 | 34.58% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $57,385,602 | 24.01% |
| Atlas Venture Life Science Advisors, LLC | 9,869,483 | $114,387,308 | 13.78% |
| Logos Global Management LP | 2,150,000 | $24,918,500 | 2.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 641,068 | $7,417,157 | 2.29% |
| Deep Track Capital, LP | 2,684,200 | $31,109,878 | 1.31% |
| EcoR1 Capital, LLC | 2,322,384 | $26,916,431 | 0.82% |
| Vivo Capital, LLC | 577,642 | $6,695 | 0.77% |
| HighVista Strategies LLC | 102,431 | $1,187,175 | 0.70% |
| Monashee Investment Management LLC | 123,719 | $1,433,903 | 0.62% |